Dorzolamide Hydrochloride / Timolol Maleate

Common brands: Cosopt, Cosopt Pf, Xalatan, Alphagan P, Lumigan

Top reporter: Thea Pharma Inc.

Prostaglandin Analog [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Platelet Aggregation Inhibitor [EPC]HMG-CoA Reductase Inhibitor [EPC]
7,776
Total Reports
1,877
Serious Reports
648
Death Reports
30
Reported Reactions
Death Report Ratio: High (8.33%)

Patient Demographics

Male
2,952
Female
4,379

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Dorzolamide Hydrochloride / Timolol Maleate.

# Reaction Reports % of Total
1 EYE IRRITATION 787
9.4%
2 OCULAR HYPERAEMIA 643
7.7%
3 DRUG INEFFECTIVE 585
7.0%
4 EYE PAIN 481
5.7%
5 EYE PRURITUS 393
4.7%
6 INTRAOCULAR PRESSURE INCREASED 364
4.3%
7 DEATH 335
4.0%
8 VISION BLURRED 328
3.9%
9 GLAUCOMA 277
3.3%
10 FATIGUE 273
3.3%
11 DYSPNOEA 262
3.1%
12 EYE SWELLING 249
3.0%
13 OFF LABEL USE 240
2.9%
14 HEADACHE 224
2.7%
15 DIZZINESS 215
2.6%
16 HYPERSENSITIVITY 215
2.6%
17 FALL 213
2.5%
18 LACRIMATION INCREASED 208
2.5%
19 NAUSEA 208
2.5%
20 ASTHENIA 199
2.4%
21 DIARRHOEA 198
2.4%
22 PAIN 188
2.2%
23 VISUAL IMPAIRMENT 173
2.1%
24 VOMITING 171
2.0%
25 PNEUMONIA 167
2.0%
26 HYPERTENSION 160
1.9%
27 DRUG HYPERSENSITIVITY 159
1.9%
28 VISUAL ACUITY REDUCED 156
1.9%
29 TREATMENT FAILURE 153
1.8%
30 CATARACT 152
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.